Compare ANL & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | GOOD |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | United States |
| Employees | 109 | 72 |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 611.1M | 607.0M |
| IPO Year | 2022 | N/A |
| Metric | ANL | GOOD |
|---|---|---|
| Price | $9.36 | $12.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $20.00 | $12.50 |
| AVG Volume (30 Days) | 144.9K | ★ 597.2K |
| Earning Date | 04-10-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 9.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.02 | $9.89 |
| Revenue Next Year | N/A | $2.57 |
| P/E Ratio | ★ N/A | $62.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $10.33 |
| 52 Week High | $17.25 | $14.65 |
| Indicator | ANL | GOOD |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 55.53 |
| Support Level | $9.46 | $12.19 |
| Resistance Level | $9.98 | $12.92 |
| Average True Range (ATR) | 1.35 | 0.26 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 27.46 | 82.32 |
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.